Vaccines

Patricia Smith, President of the Lyme disease Association Inc., discusses Lyme disease infection prevention.

While the 2016 Ebola outbreak in the Democratic Republic of Congo continues to unfold, researchers have identified the first natural human antibodies against all three major disease-causing ebolaviruses.

Researchers from Beaumont hospital have developed a Zika virus diagnostic test that yields quick results. In addition, a Zika vaccine may be coming our way, but perhaps not in the way we hoped.

On HIV Vaccine Awareness Day, we reflect on the advancements made in the fight against HIV and the ongoing efforts to reach the collective goal of developing a safe, effective vaccine.

This week’s Public Health News Watch focuses on what’s potentially behind the recent outbreak of measles in a Somali community in Minnesota.

CDC researchers have found that an invasive serotype of Streptococcus pneumoniae belonging to nonvaccine serotype 35B has recently emerged.

As widespread and regional flu activity in the United States continues to dwindle, health officials are ready to say "goodbye" to flu season as they channel their efforts into preparing for the next one.

There are several diseases that pose a high risk in the dental healthcare setting; a review article highlights ones that are preventable by immunization.

In a recent webinar, the CDC and the HHS’s National Vaccine Program Office discussed global efforts being made to eradicate polio, measles, and rubella in the United States.

Health officials in Minnesota have linked the state’s biggest measles outbreak in decades to anti-vaccination efforts centered on one immigrant community.

In a collaborative effort, scientists from Johns Hopkins School of Medicine and George Washington University have found that defective HIV proviruses can complicate monitoring the true viral load within patients and distract the immune system from attacking the functional virus.

In case you missed them, here are our top 5 articles for the week of April 23, 2017.

Manufacturing issues have led to a shortage of the only yellow fever vaccine licensed in the United States; now, that shortage is expected to lead to a complete depletion of available vaccine by mid-2017.

The CDC offers insight into why a rare exception to the general recommendation of either brand of MenB vaccine had been made for the Rutgers outbreak in 2016.

On World Malaria Day, the world focuses on how to eliminate malaria once and for all.

Study results presented today at the 2017 66th Annual EIS Conference provided the first statistical evidence for herd protection from the human papillomavirus (HPV) vaccine.

Although the eradication of smallpox was declared by the World Health Assembly in 1980, the deadly disease might make a comeback. The question is, will we be prepared for it?

Researchers find that children of parents or caregivers who receive the season flu shot are more likely than others to also be immunized.

While flu season in the United States continues to wane, a new study from a team of researchers details the surprising discovery of a compound that may be a powerful flu-fighter.

A new mathematical model developed by Yale School of Public Health estimates that vaccines used in tandem with interventions can potentially avert millions of HIV cases in the upcoming years.

Researchers from The University of Texas Medical Branch at Galveston (UTMB) and Instituto Evandro Chagas (IEC) have published their findings on the live-attenuated vaccine candidate in the journal Nature Medicine.

A new report released by the Centers for Disease Control and Prevention (CDC) has found that nearly half of US adults have some form of genital HPV.

In case you missed them, here are our top 5 articles for the week of April 2, 2017.

Sometimes the best surveillance tools are found in the gutter, at least according to a new study.

During a recent webcast lecture, Hana Golding, PhD from the US Food and Drug Administration described new ways to evaluate safety and effectiveness of vaccine adjuvants.